Abstracts tagged "IgG4 Related Disease and treatment"

Abstract Number: 1775 • 2018 ACR/ARHP Annual Meeting
IgG4-Related Disease, Clinical Series on Chilean Patients
Carolina Cuéllar¹, Oscar Neira^2,3, Alejandra Herrera⁴, Miguel Gutérrez⁵, Fabián Elgueta⁶, Pamela Wurmann⁶, Bellanides Mansilla^4,7, Javier Basualdo^2,8, Jorge Vega⁵, Daniel Erlij², Cristián Labarca³, Cristián Vergara⁵, Verónica Mezzano^9,10, Paula Pastenes¹¹, Lilith Stange¹², Susana Michalland², Francisco Silva³, Aquiles Jara¹³, I. Annelise Goecke⁶, Carolina Llanos⁹, María Badilla², Rodrigo Tagle¹³, Paula Burgos⁹, Mirentxu Iruretagoyena⁹, Patricio Sandoval¹⁴, Cristina Fernández¹⁵ and Carolina Landeros¹⁶, ¹Rheumatology Section., Hospital del Salvador, Universidad de Chile., SANTIAGO, Chile, ²Rheumatology Section., Hospital del Salvador, Universidad de Chile., Santiago, Chile, ³Rheumatology Unit, Clinica Alemana de Santiago. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile, ⁴Rheumatology Departament, Pontificia Universidad Católica de Chile., Santiago, Chile, ⁵Hospital Naval Almirante Nef, Viña del Mar., Viña del Mar, Chile, ⁶Rheumatology Section, Hospital Clínico Universidad de Chile, Santiago, Chile, ⁷Hospital Clínico Magallanes, Punta Arenas, Chile, ⁸Clínica Santa María de Santiago., Santiago, Chile, ⁹Rheumatology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, ¹⁰Clínica Las Condes., Santiago, Chile, ¹¹Hospital Carlos Van Buren, Valparaíso, Chile, ¹²Clínica Ciudad del Mar, Viña del Mar, Chile, ¹³Nephrology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, ¹⁴Neurology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, ¹⁵Instituto Nacional del Tórax., Santiago, Chile, ¹⁶Internal Medicine Service., Hospital del Salvador, Universidad de Chile., Santiago, Chile
Background/Purpose: IgG4-related disease (IgG4-RD) is a chronic fibroinflammatory condition that can affect almost any organ. Gold standard for diagnosis, biopsy, can shows lymphoplasmacytic infiltration, storiform…
Abstract Number: 941 • 2016 ACR/ARHP Annual Meeting
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index
Zachary Wallace¹, Arezou Khosroshahi², Mollie Carruthers³, Campochiaro Corrado⁴, Hyon K. Choi⁵, Emma Culver⁶, Frank Cortazar⁷, Mikael Ebbo⁸, Ana Fernandes⁹, Luca Frulloni¹⁰, Omer Karadag¹¹, Shigeyuki Kawa¹², Mitsuhiro Kawano¹³, MH Kim¹⁴, Marco Lanzillotta¹⁵, Shoko Matsui¹⁶, Cory Perugino¹⁷, Kazuichi Okazaki¹⁸, Philip Hart¹⁹, Jay H. Ryu²⁰, Takako Saeki²¹, Nicolas Schleinitz²², Paula Tanasa²³, Hisanori Umehara²⁴, George Webster²⁵, Wen Zhang²⁶ and John H. Stone²⁷, ¹Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ²Medicine, Emory University School of Medicine, Atlanta, GA, ³Rheumatology, University of British Columbia, Vancouver, BC, Canada, ⁴San Raffaele Scientific Institute, Milan, Italy, ⁵Rheumatology, Allergy and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, ⁶Translational Gastroenterology Unit and NDM Oxford University, Translational Gastroenterology Unit and NDM Oxford University, John Radcliffe Hospital/Oxford University, Oxford, United Kingdom, ⁷Department of Nephrology, Massachusetts General Hospital, Boston, MA, ⁸Internal Medicine, Aix-Marseille Université, AP-HM, Marseille, France, ⁹Rheumatology Unit, Massachusetts General Hospital, Boston, MA, ¹⁰Gastroenterology, University of Verona, Verona, Italy, ¹¹Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ¹²Center for Health, Safety and Environmental Management, Shinshu University, Matsumoto, Japan, ¹³Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Japan, ¹⁴University of Ulsan College of Medicine, Seoul, Korea, The Republic of, ¹⁵Vita-Salute San Raffaele University, Milan, Italy, ¹⁶University of Toyama, Toyama, Japan, ¹⁷Rheumatology, Massachusetts General Hospital, Boston, MA, ¹⁸Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan, ¹⁹Ohio State University Wexner Medical Center, Columbus, OH, ²⁰Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, ²¹Nagaoka Red Cross Hospital, Niigata, Japan, ²²La Timone University Hospital, Marseille, France, ²³Rheumatology, Emory University, Atlanta, GA, ²⁴Kyoto University, Kyoto, Japan, ²⁵University College Hospital, London, United Kingdom, ²⁶Rheuamtology, Peking Union Medical College Hospital, Beijing, China, ²⁷Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA
Background/Purpose: IgG4-related disease (IgG4-RD) is an immune-mediated condition responsible for fibro-inflammatory lesions that can affect nearly any organ and lead to irreversible damage. To evaluate…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].